These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34728188)

  • 1. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
    Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
    Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active targeted delivery of theranostic thermo/pH dual-responsive magnetic Janus nanoparticles functionalized with folic acid/fluorescein ligands for enhanced DOX combination therapy of rat glioblastoma.
    Ali BH; Khoee S; Mafakheri F; Sadri E; Mahabadi VP; Karimi MR; Shirvalilou S; Khoei S
    J Mater Chem B; 2024 Jun; 12(24):5957-5973. PubMed ID: 38808630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid conjugated Fe
    Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
    Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
    Kaamyabi S; Badrian A; Akbarzadeh A
    Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of novel superparamagnetic Ni
    Qasim M; Asghar K; Dharmapuri G; Das D
    Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique.
    Dey C; Ghosh A; Ahir M; Ghosh A; Goswami MM
    Chemphyschem; 2018 Nov; 19(21):2872-2878. PubMed ID: 30133086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
    Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells.
    Luesakul U; Puthong S; Neamati N; Muangsin N
    Carbohydr Polym; 2018 Feb; 181():841-850. PubMed ID: 29254044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
    Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
    PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polylactide-based Magnetic Spheres as Efficient Carriers for Anticancer Drug Delivery.
    Mhlanga N; Sinha Ray S; Lemmer Y; Wesley-Smith J
    ACS Appl Mater Interfaces; 2015 Oct; 7(40):22692-701. PubMed ID: 26390359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
    Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple preparation of maltose-functionalized dendrimer/graphene quantum dots as a pH-sensitive biocompatible carrier for targeted delivery of doxorubicin.
    Karimi S; Namazi H
    Int J Biol Macromol; 2020 Aug; 156():648-659. PubMed ID: 32289413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.
    Hosseini Sadr S; Davaran S; Alizadeh E; Salehi R; Ramazani A
    J Biomater Sci Polym Ed; 2018 Feb; 29(3):277-308. PubMed ID: 29212412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle-shaped amphoteric calix[4]arene as a magnetic nanocarrier for simultaneous delivery of anticancer drugs to the breast cancer cells.
    Rahimi M; Karimian R; Noruzi EB; Ganbarov K; Zarei M; Kamounah FS; Yousefi B; Bastami M; Yousefi M; Samadi Kafil H
    Int J Nanomedicine; 2019; 14():2619-2636. PubMed ID: 31043778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.